# An Ascending Dose Study of PIT565 in Participants With Rheumatoid Arthritis

> **NCT07029555** · PHASE1 · RECRUITING · sponsor: **Novartis Pharmaceuticals** · enrollment: 57 (estimated)

## Conditions studied

- Rheumatoid Arthritis

## Interventions

- **BIOLOGICAL:** PIT565

## Key facts

- **NCT ID:** NCT07029555
- **Lead sponsor:** Novartis Pharmaceuticals
- **Sponsor class:** INDUSTRY
- **Phase:** PHASE1
- **Study type:** INTERVENTIONAL
- **Status:** RECRUITING
- **Start date:** 2025-06-12
- **Primary completion:** 2028-05-15
- **Final completion:** 2028-05-16
- **Target enrollment:** 57 (ESTIMATED)
- **Last updated:** 2026-05-01


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT07029555

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT07029555, "An Ascending Dose Study of PIT565 in Participants With Rheumatoid Arthritis". Retrieved via AI Analytics 2026-06-02 from https://api.ai-analytics.org/clinical/NCT07029555. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*